J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Receipt Of ANDA Approval For Doxepin Hydrochloride Capsules USP From US FDA

J B Chemicals & Pharmaceuticals Ltd.

NSE: JBCHEPHARM | BSE: 506943 | ISIN: INE572A01036 | Industry: Pharmaceuticals
| Mid-range Performer

1625.4000 -7.50 (-0.46%)

NSE Jul 08, 2025 15:58 PM

Volume: 230.8K

J B Chemicals & Pharmaceuticals Ltd.

23 Aug 2023

1625.40

-0.46%

Company Update

J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Receipt Of ANDA Approval For Doxepin Hydrochloride Capsules USP …

BSE India

Receipt of ANDA approval for Doxepin Hydrochloride Capsules USP from US FDA

More from J B Chemicals & Pharmaceuticals Ltd.

Recommended

Market closes higher, Phoenix Mills' residential sales jump 2.4X YoY in Q1FY26

Trendlyne Marketwatch | 08 Jul 2025, 03:56PM

As IPO fever hits new high, Crizac and three other listings on the horizon

| 07 Jul 2025, 05:34PM

New leadership, fresh strategy at JB Chemicals sees impact in Q1FY23